{
    "Trade/Device Name(s)": [
        "Tina-quant Albumin Gen. 2",
        "Albumin Gen. 2 assay"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K101203",
    "Predicate Device Reference 510(k) Number(s)": [
        "K932950",
        "K972929",
        "K953239"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DCF"
    ],
    "Summary Letter Date": "September 9, 2010",
    "Summary Letter Received Date": "September 10, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.5040"
    ],
    "Regulation Name(s)": [
        "Albumin Immunological Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Albumin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine",
        "Cerebrospinal fluid (CSF)"
    ],
    "Specimen Container(s)": [
        "Li-heparin tube",
        "K2-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Roche/Hitachi cobas c analyzer",
        "cobas c501"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Immunoturbidimetry"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Tina-quant Albumin Gen. 2 immunoturbidimetric assay to quantitatively measure albumin in serum, plasma, urine, and CSF on Roche/Hitachi cobas c systems",
    "Indications for Use Summary": "Immunoturbidimetric assay for quantitative determination of albumin in serum, plasma, urine, and CSF; measurement aids diagnosis of kidney and intestinal diseases",
    "fda_folder": "Immunology"
}